Abstract
Numeral abnormality of centrosomes (presence of more than two centrosomes) leads to mitotic defects and high frequencies of chromosome segregation errors. Centrosome amplification occurs frequently in various types of human cancers, and is believed to be a major cause of chromosomal instability. Centrosome amplification in many cases results from over-duplication (more than one duplication in a single cell cycle) caused by aberrant activities of the positive and negative regulators of centrosome duplication. Centrosome duplication is triggered by the cyclin-dependent kinase 2 (CDK2)-cyclin E kinase complex through targeting several centrosomally localized proteins, including Mps1 kinase. In contrast, p53 tumor suppressor protein suppresses centrosome duplication partly through transactivating p21 CDK inhibitor, and partly through direct regulation at centrosomes. Mortalin localizes to centrosomes, and when overexpressed, promotes centrosome duplication and induces centrosome amplification via targeting both Mps1 and p53. Here, we discuss the involvement of mortalin in the regulation of centrosome duplication and re-duplication, revealing a new and important aspect of oncogenic activity of mortalin, namely induction of numeral abnormality of centrosomes and consequent chromosome instability.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Blair Zajdel ME, Blair GE (1988) The intracellular distribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells. Oncogene 2:579–584
Brown CR, Doxsey SJ, White E, Welch WJ (1994) Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes. J Cell Physiol 160:47–60
Carroll PE, Okuda M, Horn HF, Biddinger P, Stambrook PJ, Gleich LL, Li YQ, Fukasawa K (1998) Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 18:1935–1944
Chen Z, Indjeian VB, McManus M, Wang L, Dynlacht BD (2002) CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell 3:339–350
D’Assoro AB, Lingle WL, Salisbury JL (2002) Centrosome amplification and the development of cancer. Oncogene 21:6146–6153
Dundas SR, Lawrie LC, Rooney PH, Murray GI (2005) Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol 205:74–81
Fisk HA, Winey M (2001) The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106:95–104
Fisk HA, Mattison CP, Winey M (2003) Human Mps1 protein kinase is required for centrosome duplication and normal mitotic progression. Proc Natl Acad Sci U S A 100:14875–14880
Fukasawa K (2005) Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230:6–19
Fukasawa K (2007) Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 7:911–924
Ganem NJ, Godinho SA, Pellman D (2009) A mechanism linking extra centrosomes to chromosomal instability. Nature 460:278–282
Hanashiro K, Kanai M, Geng Y, Sicinski P, Fukasawa K (2008) Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells. Oncogene 27:5288–5302
Harper JW (1997) Cyclin dependent kinase inhibitors. Cancer Surv 29:91–107
Hinchcliffe HE, Li C, Thompson EA, Maller JL, Sluder G (1999) Requirement of Cdk2--cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851–854
Hsu LC, Kapali M, Deloia JA, Gallion HH (2005) Centrosome abnormalities in ovarian cancer. Int J Cancer 113:746–751
Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S, Katz RL (2003) Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer 106:661–665
Kanai M, Ma Z, Izumi H, Kim SH, Mattison CP, Winey M, Fukasawa K (2007) Physical and functional interaction between mortalin and Mps1 kinase. Genes Cells 12:797–810
Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K, Fukasawa K (2004) Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 64:4800–4809
Koutsami MK, Tsantoulis PK, Kouloukoussa M, Apostolopoulou K, Pateras IS, Spartinou Z, Drougou A, Evangelou K, Kittas C, Bartkova J, Bartek J, Gorgoulis VG (2006) Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression. J Pathol 209:512–521
Krämer A, Schweizer S, Neben K, Giesecke C, Kalla J, Katzenberger T, Benner A, Müller-Hermelink HK, Ho AD, Ott G (2003) Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin’s lymphoma. Leukemia 17:2207–2213
Lacey KR, Jackson PK, Stearns T (1999) Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci U S A 96:2817–2822
Lingle WL, Barrett SL, Negron VC, D’Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL (2002) Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci U S A 99:1978–1983
Ma Z, Izumi H, Kanai M, Kabuyama Y, Ahn NG, Fukasawa K (2006) Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene 25:5377–5390
Mazia D (1987) The chromosome cycle and the centrosome cycle in the mitotic cycle. Int Rev Cytology 100:49–92
Mikule K, Delaval B, Kaldis P, Jurcyzk A, Hergert P, Doxsey S (2007) Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest. Nat Cell Biol 9:160–170
Morris VB, Brammall J, Noble J, Reddel R (2000) p53 localizes to the centrosomes and spindles of mitotic cells in the embryonic chick epiblast, human cell lines, and a human primary culture: an immunofluorescence study. Exp Cell Res 256:122–130
Nakajima T, Moriguchi M, Mitsumoto Y, Sekoguchi S, Nishikawa T, Takashima H, Watanabe T, Katagishi T, Kimura H, Okanoue T, Kagawa K (2004) Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma. Mod Pathol 17:722–727
Neben K, Tews B, Wrobel G, Hahn M, Kokocinski F, Giesecke C, Krause U, Ho AD, Krämer A, Lichter P (2004) Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes. Oncogene 23:2379–2384
Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429
Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K (2000) Nucleophosmin/B23 is a target of CDK2--cyclin E in centrosome duplication. Cell 103:127–140
Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ (1998) Centrosome defects and genetic instability in malignant tumors. Cancer Res 58:3974–3985
Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ (2001) Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 61:2212–2219
Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39–85
Sato N, Mizumoto K, Nakamura M, Nakamura K, Kusumoto M, Niiyama H, Ogawa T, Tanaka M (1999) Centrosome abnormalities in pancreatic ductal carcinoma. Clin Cancer Res 5:963–970
Sherr CJ (2006) Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6:663–673
Shinmura K, Bennett RA, Tarapore P, Fukasawa K (2007) Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication. Oncogene 26:2939–2944
Tarapore P, Horn HF, Tokuyama Y, Fukasawa K (2001a) Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene 20:3173–3184
Tarapore P, Tokuyama Y, Horn HF, Fukasawa K (2001b) Difference in the centrosome duplication regulatory activity among p53 ‘hot spot’ mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53. Oncogene 20:6851–6863
Tarapore P, Okuda M, Fukasawa K (2002) A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and Nucleophosmin/B23 in centrosome duplication. Cell Cycle 1:75–81
Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803–1815
Tritarelli A, Oricchio E, Ciciarello M, Mangiacasale R, Palena A, Lavia P, Soddu S, Cundari E (2004) p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation. Mol Biol Cell 15:3751–3757
Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR, Mitsui Y, Kaul SC (1998) Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem 273:29586–29591
Weber RG, Bridger JM, Benner A, Weisenberger D, Ehemann V, Reifenberger G, Lichter P (1998) Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenet. Cell Genet 83:266–269
Winey M, Goetsch L, Baum P, Byers B (1991) MPS1 and MPS2: novel yeast genes defining distinct steps of spindle pole body duplication. J Cell Biol 114:745–754
Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY, Lau GK, Beretta L, Fan ST (2008) Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics 7:315–325
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Kanai, M., Fukasawa, K. (2012). Mortalin: A Positive Regulator of Centrosome Duplication and Amplification. In: Kaul, S., Wadhwa, R. (eds) Mortalin Biology: Life, Stress and Death. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-3027-4_15
Download citation
DOI: https://doi.org/10.1007/978-94-007-3027-4_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-3026-7
Online ISBN: 978-94-007-3027-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)